Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Scott Stroup

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
The American Journal of Psychiatry|February 1, 2026
Comparative Effectiveness Trials and the Quest for Personalized Treatments: The Case of AntipsychoticsT Scott Stroup
Revista De Psiquiatria Y Salud Mental|October 23, 2012
The need to determine the best options for people with schizophrenia that is unresponsive to treatmentT Scott Stroup
The Journal of Clinical Psychiatry|December 4, 2014
What is the role of long-acting injectable antipsychotics in the treatment of schizophrenia?T Scott Stroup
JAMA Psychiatry|August 1, 2019
Clozapine and Evidence-Based Psychopharmacology for SchizophreniaT Scott Stroup
Evidence-Based Mental Health|July 27, 2006
Review: higher rates of attrition in antipsychotic treatment arms of placebo controlled trials than in trials with active comparatorsT Scott Stroup
The American Journal of Psychiatry|February 8, 2011
What can large simple trials do for psychiatry?T Scott Stroup
The American Journal of Medicine|April 4, 2007
Heterogeneity of treatment effects in schizophreniaT Scott Stroup
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 8, 2018
Management of common adverse effects of antipsychotic medicationsT Scott Stroup, Neil Gray
Current Opinion in Psychiatry|January 16, 2013
Polypharmacy for schizophreniaJacob Ballon, T Scott Stroup
International Journal of Clinical Practice|August 9, 2006
Schizophrenia, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and number needed to treat: how can CATIE inform clinicians?L Citrome, T Scott Stroup
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
The American Journal of Psychiatry|February 1, 2026
Comparative Effectiveness Trials and the Quest for Personalized Treatments: The Case of AntipsychoticsT Scott Stroup
Revista De Psiquiatria Y Salud Mental|October 23, 2012
The need to determine the best options for people with schizophrenia that is unresponsive to treatmentT Scott Stroup
The Journal of Clinical Psychiatry|December 4, 2014
What is the role of long-acting injectable antipsychotics in the treatment of schizophrenia?T Scott Stroup
JAMA Psychiatry|August 1, 2019
Clozapine and Evidence-Based Psychopharmacology for SchizophreniaT Scott Stroup
Evidence-Based Mental Health|July 27, 2006
Review: higher rates of attrition in antipsychotic treatment arms of placebo controlled trials than in trials with active comparatorsT Scott Stroup
The American Journal of Psychiatry|February 8, 2011
What can large simple trials do for psychiatry?T Scott Stroup
The American Journal of Medicine|April 4, 2007
Heterogeneity of treatment effects in schizophreniaT Scott Stroup
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 8, 2018
Management of common adverse effects of antipsychotic medicationsT Scott Stroup, Neil Gray
Current Opinion in Psychiatry|January 16, 2013
Polypharmacy for schizophreniaJacob Ballon, T Scott Stroup
International Journal of Clinical Practice|August 9, 2006
Schizophrenia, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and number needed to treat: how can CATIE inform clinicians?L Citrome, T Scott Stroup
Pageof 15